Skip to main content
PEGASUS MERCANTILE INC. logo

PEGASUS MERCANTILE INC. — Investor Relations & Filings

Ticker · LOAN ISIN · CA70557Y2042 LEI · 529900BGK3BYC4VSF690 CSE Financial and insurance activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2021-01-29 Regulatory Filings
Country CA Canada
Listing CSE LOAN

About PEGASUS MERCANTILE INC.

https://xtacytherapeutics.com/

Pegasus Mercantile Inc. is a diversified venture capital firm and prospect generator that provides financial, operational, and management assistance to high-growth companies. The firm specializes as an incubator for early-stage investments within the wellness consumer goods market, focusing on biotechnology, hemp, CBD, functional mushrooms, and psychedelics. Its investment strategy targets solutions for chronic pain, depression, and mental illness, often utilizing pioneering techniques such as micro-dosing organic and synthetic compounds. Pegasus Mercantile assists portfolio companies from startup through commercialization, specializing in navigating complex regulatory requirements, including clinical trials, patenting, and legislative approvals. The firm also provides debt financing facilities.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-502Fl CLASS 1 AND CLASS 3B REPORTING ISSUERS - PARTICIPATION FEE' and includes a 'MANAGEMENT CERTIFICATION' by an officer of the reporting issuer. The text indicates this form is submitted to the Ontario Securities Commission and certifies the completeness and accuracy of the information provided. The document references specific reporting issuer classifications and trading periods but does not contain financial statements or detailed financial analysis. It is primarily a certification form related to regulatory compliance and fee reporting rather than a financial report or announcement of financial results. Given the nature of the document as a regulatory form with officer certification, it fits best under Regulatory Filings (RNS) according to the Certification Rule and fallback category guidelines.
2021-01-29 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-501Fl' and is described as a 'Management Certification' submitted to the Alberta Securities Commission. It includes a certification statement by an officer (CFO) certifying the completeness and accuracy of the information provided in the form. The document references reporting issuer information, trading periods, and market value of securities. There is no substantive financial data or detailed financial statements present; rather, it is a certification related to regulatory compliance. The document length is 7,258 characters, which is relatively short and consistent with a certification or attestation document rather than a full financial report. According to the rules, documents that are primarily officer certifications or attestations, even if referencing financial reports, should be classified as Regulatory Filings (RNS). Therefore, this document is best classified as a Regulatory Filing (RNS).
2021-01-29 English
Audited annual financial statements – English.pdf
Regulatory Filings
2021-01-29 English
News release - English.pdf
Regulatory Filings
2021-01-27 English
Other securityholders documents - English.pdf
Regulatory Filings Classification · 95% confidence The document is an attestation signed by the CEO regarding the re-filing of the interim financial report and management report for the period ended September 30, 2020. It confirms the accuracy and completeness of the interim documents and the adequacy of internal controls. The text does not contain the actual interim financial statements or substantive financial data but is a certification related to those reports. According to the CERTIFICATION RULE, such attestations or officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is 4036 characters, which is relatively short and consistent with a certification letter rather than a full report.
2021-01-26 English
Other securityholders documents - English.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from Computershare Investor Services Inc. confirming the mailing of materials related to Redfund Capital Corp.'s consolidation and name change to Global Wellness Strategies Inc. It mentions sending a Letter of Transmittal and Security return envelope to shareholders. The document is short (2048 characters) and serves as a confirmation of mailing rather than containing any financial data, report content, or detailed disclosures. It does not present financial results, management discussion, voting results, or regulatory filings per se. It is essentially an administrative confirmation related to shareholder communications. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2021-01-26 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.